OR WAIT null SECS
December 16, 2016
The companies entered a manufacturing agreement for the future commercial production of Lenti-D and LentiGlobin product candidates.
Univercells received a grant from the Bill & Melinda Gates Foundation for the development of a vaccine manufacturing platform.
December 15, 2016
Oxford Genetics received £1.61 million from Innovate UK to explore computational and synthetic biology approaches for optimized mammalian bioproduction.
GlaxoSmithKline opened a new vaccines R&D center in Rockville, MD creating up to 200 new jobs.
December 14, 2016
BMS changes its US geographic footprint with R&D investments and closures.
December 08, 2016
At the American Society of Hematology Annual Meeting, Novartis and Kite Pharma both released results from early-phase clinical trials with CAR-T therapies.
Spark Therapeutics and Selecta entered a license agreement for Selecta’s gene-therapy co-administration technology.
December 07, 2016
Takeda and Lightstone have launched Cerevance, a neuroscience company focused on developing therapeutics for neurological and psychiatric disorders.
JHL Biotech and Sanofi collaborate on the development and commercialization of biological therapeutics in China.
December 02, 2016
Boehringer Ingelheim and China Southeast University announced a joint research collaboration to develop new regenerative treatments for hearing loss.